Production (Stage)
BioAge Labs, Inc.
BIOA
$3.98
$0.030.76%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 320.52M | 354.35M | 334.47M | 159.09M | 173.99M |
| Total Receivables | 1.46M | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.83M | 2.75M | 1.99M | 4.57M | 1.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 3.31M |
| Total Current Assets | 324.81M | 357.10M | 336.47M | 163.65M | 178.81M |
|
|
|||||
| Total Current Assets | 324.81M | 357.10M | 336.47M | 163.65M | 178.81M |
| Net Property, Plant & Equipment | 4.13M | 791.00K | 814.00K | 625.00K | 696.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 239.00K | 240.00K | -- | 25.00K | -- |
| Total Assets | 343.84M | 358.23M | 337.38M | 164.40M | 179.60M |
|
|
|||||
| Total Accounts Payable | 3.99M | 2.00M | 2.10M | 1.47M | 2.32M |
| Total Accrued Expenses | 4.31M | 11.33M | 8.97M | 3.92M | 2.64M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.70M | 6.20M | 6.27M | 6.30M | 6.30M |
| Total Finance Division Other Current Liabilities | 8.74M | 8.24M | 1.74M | 1.30M | 3.89M |
| Total Other Current Liabilities | 8.74M | 8.24M | 1.74M | 1.30M | 3.89M |
| Total Current Liabilities | 23.74M | 27.78M | 19.08M | 12.98M | 15.14M |
|
|
|||||
| Total Current Liabilities | 23.74M | 27.78M | 19.08M | 12.98M | 15.14M |
| Long-Term Debt | 1.06M | 2.50M | 3.94M | 5.37M | 6.79M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.56M | -- | -- | 43.00K | 110.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.32M | 4.83M | 613.00K | 307.00K | 237.00K |
| Total Liabilities | 30.67M | 35.11M | 23.63M | 18.70M | 22.28M |
|
|
|||||
| Common Stock & APIC | 578.64M | 575.69M | 545.32M | 10.98M | 9.00M |
| Retained Earnings | -265.74M | -252.81M | -231.68M | -208.28M | -194.69M |
| Treasury Stock & Other | 264.00K | 245.00K | 109.00K | 167.00K | 185.00K |
| Total Common Equity | 313.17M | 323.13M | 313.75M | -197.13M | -185.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 342.83M | 342.83M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 342.83M | 342.83M |
|
|
|||||
| Total Common Equity | 313.17M | 323.13M | 313.75M | -197.13M | -185.51M |
| Total Preferred Equity | -- | -- | -- | 342.83M | 342.83M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 313.17M | 323.13M | 313.75M | 145.70M | 157.32M |
|
|
|||||